Incipiam means ”I will begin” and that is where we believe we are – at the forefront of a paradigm shift in metabolic disease treatment.
Most treatment options currently in development for metabolic disease focus on reduction of energy intake. While this is important, we see a new era of weight loss therapeutics emerging, where reduction in energy intake is insufficient to advance both the understanding of metabolic disease but also to drive development of novel treatments.
At Incipiam Pharma, we're pioneering the next wave of weight loss therapeutics, targeting energy expenditure to revolutionize treatment for those living with obesity and diabetes.
Company Details
- Employees
- 2
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://incipiampharma.com
- Keywords
- IT Consulting.
Incipiam Pharma Questions
Incipiam Pharma's website is http://incipiampharma.com
Incipiam Pharma's LinkedIn profile is https://www.linkedin.com/company/incipiampharma
Incipiam Pharma has
2 employees.
View email and phone details for 2
employees at Incipiam Pharma.
Incipiam Pharma's industry is
Biotechnology Research
Incipiam Pharma's top competitors are
Incipiam,
Proxi Biotech,
Akasi Pharma,
3sonic,
Synuca Therapeutics,
Microminer,
Beech Biotech Sa,
Xterna,
Gefjon Pharma,
Yngvi Bio.
Incipiam Pharma's categories are Biotechnology Research
